Eledon Pharmaceuticals, Inc.

ELDN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$20,549$4,612$56,409$84,833
Short-Term Investments$119,629$46,490$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$729$90$28$34
Total Curr. Assets$143,730$56,129$59,518$88,346
Property Plant & Equip (Net)$926$365$739$768
Goodwill$0$0$0$48,648
Intangibles$32,386$32,386$32,386$32,386
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$363$186$150$400
Total NC Assets$33,675$32,937$33,275$82,202
Other Assets$0$0$0$0
Total Assets$177,405$89,066$92,793$170,548
Liabilities
Payables$5,833$967$2,200$1,813
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,601$2,003$0$1,515
Total Curr. Liab.$11,577$3,895$6,475$4,401
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,183$1,752$0$1,752
Other NC Liab.$44,865$76,211$1,752$0
Total NC Liab.$47,688$77,963$2,135$2,152
Other Liabilities$0$0$0$0
Cap. Leases$954$383$746$769
Total Liabilities$59,265$81,858$8,610$6,553
Equity
Pref Stock$55,694$0$0$0
Common Stock$60$24$14$14
Retained Earnings-$355,586-$319,402-$202,865-$114,899
AOCI$26$0$0$0
Other Equity$0$0-$0$0
Total Equity$118,140$7,208$84,183$163,995
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$177,405$89,066$92,793$170,548
Net Debt-$20,549-$4,612-$56,409-$84,833